Andere Sprachen Chimerix, Inc.

Aktien

A1T65B

US16934W1062

CMRX

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 25.04.2024			% 5 Tage	% 1. Jan.
0,891 ^USD	-1,66 %		-4,43 %	-7,43 %

21.03.	Chimerix ernennt Marc D. Kozin zum Vorstandsmitglied	CI
29.02.	Transcript : Chimerix, Inc., Q4 2023 Earnings Call, Feb 29, 2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024	24.04.
Chimerix Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	17.04.
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	16.04.
Chimerix Appoints Marc D. Kozin to Board of Directors	21.03.
Chimerix Appoints Marc D. Kozin to Board of Directors	21.03.
Chimerix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29.02.
Chimerix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29.02.
Chimerix: Q4 Earnings Snapshot	29.02.
Earnings Flash (CMRX) CHIMERIX Reports Q4 Revenue $4,000, vs. Street Est of $70,000	29.02.
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update	29.02.
Chimerix to Present at TD Cowen 44th Annual Health Care Conference	27.02.
Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024	22.02.
Chimerix Announces Board Changes	29.12.
Chimerix Appoints Lisa Decker to Board of Directors	29.12.
Chimerix Names Michelle LaSpaluto Finance Chief	04.12.
Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer	04.12.
Chimerix, Inc. Promotes Michelle Laspaluto to the Position of Chief Financial Officer	04.12.
Chimerix Reports Inducement Grant under Nasdaq Listing Rule 5635(4)	27.11.
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	24.11.
Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer	16.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Chimerix, Inc.

Aktien

A1T65B

US16934W1062

CMRX

Andere Sprachen

Filter